Login
  

Welcome! The Huntington Study Group (HSG) is a non-profit group of clinical investigators from medical centers in the United States, Canada, Europe, Australia, New Zealand and South America experienced in the care of patients and families affected by Huntington disease and dedicated to clinical research of this hereditary disorder. The HSG focuses on the conception, conduct and communication of clinical research, including treatment trials and observational studies aimed at relieving the burden and slowing the progression of Huntington disease. Please see Clinical Trials and Observational Studies in Progress for the current HSG trials.


 

NOW ENROLLING!!!!!!
March 2010 - PREQUEL is now enrolling.

ENROLLING TRIALS AND STUDIES
March 2010 - The treatment trials that are currently enrolling 2CARE, CREST-EHART and HORIZON, PREQUEL.
March 2010 - The observational studies that are currently enrolling are COHORT and PREDICT-HD.
Please see Clinical Trials and Observational Studies in Progress for a list of all ongoing HSG trials.

HUNTINGTON SOCIETY OF CANADA/HSG RESEARCH GRANT
Deadline for full proposals is March 23, 2010 
Please see Request for Proposals for more information.

HSG Press Release...

HSG and EHDN Begin Joint Phase III Study in Huntington Disease (HD). February 2010


This is an exciting and busy time for HD researchers and the community. The Huntington Study Group has 7 studies that are either enrolling, or soon to be enrolling participants. Please see the HSG Study Flyer (June 2009) for a detailed chart view of these enrolling studies and clinical trials. Feel free to print the information and discuss it with your family, friends and medical professionals.